Fight against hopelessness Curocell, a leader of development of innovative immune cell therapy, reaches out a hand to numbers of cancer patients in despair Curocell, a leader of developing innovative anti-cancer immune cell therapy, reaches out a hand to numbers of cancer patients in despair
About

We are developing innovative immune
cell therapy
using cutting-edge gene
engineering technology.

About

We are developing innovative immune
cell therapy
using cutting-edge gene
engineering technology.

We are developing innovative immune cell therapy using cutting-edge gene engineering technology.

NEWS

큐로셀, 시리즈C 440억원 투자유치… CAR-T 개발 가속화

바이오 전문 투자기관 대거 참여 CAR-T 치료제 개발 전문기업 큐로셀은 440억원 규모의 ‘시리즈C’ 투자 유치에 성공했다고 10일 밝혔다. 2017년 창업…

큐로셀, 삼성서울병원내 GMP 구축.. “연내 CAR-T IND”

삼성서울병원 미래의학관내 500㎡ 규모의 ‘CAR-T 생산’ GMP 시설 구축…한해 100여명의 면역세포치료제 제조 역량 확보 ▲ (왼쪽부터) 김형철 연구소장, 김원석 교수,…

NEWS

큐로셀, CAR-T 국내임상 본격화.. “임상자문 박재홍 교수 영입”

국내 임상준비 위한 임상연구 디자인, 유효성 평가방법, 부작용 관리 노하우 제공…”큐로셀 2020년 DLBCL 환자서 차세대 CD19 CAR-T 임상 계획” ▲박재홍…

큐로셀, 삼성서울병원내 GMP 구축.. “연내 CAR-T IND”

삼성서울병원 미래의학관내 500㎡ 규모의 ‘CAR-T 생산’ GMP 시설 구축…한해 100여명의 면역세포치료제 제조 역량 확보 ▲ (왼쪽부터) 김형철 연구소장, 김원석 교수,…

R&D

Our technology is evolving
beyond the limitations
of current immune cell therapies.

We expect
improved anti-cancer effects
by applying our innovative technology.

Curocell produce
the innovative immune cell product in
GMP facility that complies with current regulation.

R&D

Our technology is evolving
beyond the limitations of
current immune cell therapies.

Our technology is evolving beyond the limitations of current immune cell therapies.

We expect improved
anti-cancer effects by
applying our innovative technology.

We expect improved anti-cancer effects by applying our innovative technology.

Curocell produce the innovative
immune cell product in GMP facility
that complies with current regulation.

Curocell produce the innovative immune cell product in GMP facility that complies with current regulation.